Investments
49Portfolio Exits
2Partners & Customers
1About Capital Cell
Capital Cell is a pan-European crowdfunding platform for biotech and Life Sciences companies. Using this collective financing system, entrepreneurs can obtain the funds they need for their companies from private investors around the world.

Want to inform investors similar to Capital Cell about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Capital Cell
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Capital Cell in 1 Expert Collection, including Fintech.
Fintech
12,418 items
Excludes US-based companies
Latest Capital Cell News
May 5, 2023
All informations, projects and data are gathered from respective platforms where campaigns are hosted. While we have made every attempt to ensure that the information contained in this site has been obtained from reliable sources, Find Crowdfunding is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in this site is provided "as is", with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information, and without warranty of any kind, express or implied. Trademarks and related content are owned by their respective content. Find Crowdfunding is not a broker-dealer and the content provided here is for informational purposes only. It does not constitute an offer or solicitation to purchase any investment solution or a recommendation to buy or sell a security. Any sale or purchase of securities is in the sole discretion of, and is conducted directly between, the issuer and the prospective investor. All information regarding potential crowdfunding investment opportunities is prepared solely by the issuer, and such issuer is solely responsible for the accuracy of all such statements. Find Crowdfunding is collecting these informations from public available materials and contents and has not independently verified any such information. Direct and indirect investment in crowdfunding involves significant risks as there is a potential risk for loss of part or all of invested capital.
Capital Cell Investments
49 Investments
Capital Cell has made 49 investments. Their latest investment was in Prospera Biotech as part of their Angel on June 6, 2023.

Capital Cell Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/2/2023 | Angel | Prospera Biotech | $0.68M | Yes | 2 | |
4/14/2023 | Series B - III | mediQuo | $1.49M | Yes | 2 | |
3/16/2023 | Angel | Ephion Health | $0.46M | Yes | 3 | |
12/2/2022 | Angel | |||||
11/29/2022 | Seed |
Date | 6/2/2023 | 4/14/2023 | 3/16/2023 | 12/2/2022 | 11/29/2022 |
---|---|---|---|---|---|
Round | Angel | Series B - III | Angel | Angel | Seed |
Company | Prospera Biotech | mediQuo | Ephion Health | ||
Amount | $0.68M | $1.49M | $0.46M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 2 | 3 |
Capital Cell Portfolio Exits
2 Portfolio Exits
Capital Cell has 2 portfolio exits. Their latest portfolio exit was methinks on June 22, 2022.
Capital Cell Partners & Customers
1 Partners and customers
Capital Cell has 1 strategic partners and customers. Capital Cell recently partnered with aescuvest on January 1, 2021.
Capital Cell Team
3 Team Members
Capital Cell has 3 team members, including current Founder, Chief Executive Officer, Nigel Ten Fleming.
Name | Work History | Title | Status |
---|---|---|---|
Nigel Ten Fleming | Founder, Chief Executive Officer | Current | |
Name | Nigel Ten Fleming | ||
---|---|---|---|
Work History | |||
Title | Founder, Chief Executive Officer | ||
Status | Current |
Compare Capital Cell to Competitors
Smart Capital is a corporate finance firm that focuses on venture and private equity to support small and medium enterprises (SMEs). It focuses on biotech, high-tech, and renewable energy companies. The company was founded in 2008 and is based in Vienna, Austria.

Conda is a crowdfunding platform that connects companies that need financing and small investors. It was founded in 2012 and is based in Vienna, Austria.
ELITE connects private companies with diverse sources of capital to drive their growth. The company's network and digital platform provide companies with simplified access to diverse funding options and help intermediaries and brokers expand their reach. It is based in Milan, Italy.

Sciety is an investment syndicate that offers capital market services with a focus on life science. It specializes in investment, finance, market analysis, and more. It is based in Stockholm, Sweden.

Dutch Life Sciences Conference brings together creative entrepreneurs and expert investors. It is hosted by organisations and companies whose mission is to help realize the further development and growth of the Dutch life sciences industry. It is based in Lisse, The Netherlands.

Abingworth is an international investment group focused exclusively on the life sciences and healthcare sectors. It was founded in 1973 and is based in London, England.